RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 100 points on Monday.
今天美股盤前，納斯達克期貨上漲，道瓊斯期貨上漲約100點。
Shares of RXO, Inc.. (NYSE:RXO) shares rose sharply in today's pre-market trading after the company inked a definitive agreement to acquire Coyote Logistics from United Parcel Service, Inc. (NYSE:UPS) for $1.025 billion in cash.
聯合包裹公司從RXO公司以10.25億美元現金收購Coyote 物流公司，目前在紐交所正股盤前交易中，RXO股價大漲。
As per the terms, the transaction disclosed on Sunday will be financed through a combination of equity and debt, including a $300 million equity investment from MFN Partners and a $250 million equity investment from Orbis Investments, both significant shareholders of RXO.
根據協議，本次交易的資金來自股權和債務的組合，包括MFN Partners的3億美元股權投資和Orbis Investments的2.5億美元股權投資，兩者均爲 RXO的重要股東。
RXO shares jumped 13.3% to $22.90 in pre-market trading.
在美股盤前交易中，RXO股票暴漲13.3%，目前股價爲22.90美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares gained 38.8% to $230.00 in pre-market trading after announcing topline results from its HELIOS-B Phase 3 study of vutrisiran.
- Altimmune, Inc. (NASDAQ:ALT) shares gained 10.9% to $7.10 in pre-market trading after the company announced that it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide at the American Diabetes Association's 84th Scientific Sessions.
- Clover Health Investments, Corp. (NASDAQ:CLOV) gained 9.6% to $1.37 in pre-market trading after gaining over 21% on Friday.
- argenx SE (NASDAQ:ARGX) shares gained 9.9% to $433.52 in pre-market trading after the company announced the FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy.
- Intellia Therapeutics, Inc. (NASDAQ:NTLA) shares gained 9.5% to $26.51 in pre-market trading.
- Pharming Group N.V. (NASDAQ:PHAR) shares gained 8.1% to $7.86 in pre-market trading after declining 8% on Friday.
- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) shares gained 5.2% to $44.01 in pre-market trading.
- Alnylam Pharmaceuticals在HELIO-B第3期研究中宣佈vutrisiran的頂線結果，現在在美股盤前交易中，其股票漲了38.8%，目前股價爲230美元。
- Altimmune公司宣佈，在美國糖尿病協會84次科學會議上，公佈了pemvidutide 48周第2期MOMENTUM臨床試驗結果。目前該公司股票在美股盤前上漲10.9%，現股價爲7.10美元。
- Clover Health Investments在上週五收盤前，股價上漲超過21%，現在在美股盤前交易中，股票價格再次上漲了9.6%，目前股價爲1.37美元。
- 在美股盤前交易中，argenx se公司股價上漲9.9%，目前股價爲433.52美元，該公司宣佈獲得FDA批准上市藥品VYVGART Hytrulo，用於慢性炎性脫髓鞘性多神經病。
- Intellia Therapeutics公司股票價格在美股盤前上漲9.5%，目前股價爲26.51美元。
- Pharming Group公司股票在上週五下跌了8%，現在在美股盤前交易中，股票價格上漲了8.1%，目前股價爲7.86美元。
- Ionis Pharmaceuticals股票價格在美股盤前上漲5.2%，目前股價爲44.01美元。
Now Read This: Investor Optimism Improves Despite Stocks Ending Mixed On Friday: S&P 500 Closes Lower With Nvidia Dropping Over 3%, Dow Jones Ends Marginally Higher
投資者對未來持樂觀態度，儘管週五美股表現不佳，標普500指數收低，Nvidia股價下跌超過3%，道瓊斯指數微幅收漲。
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
譯文內容由第三人軟體翻譯。